- Home
- MIR vs VKTX Comparison
MIR vs VKTX Comparison
Compare MIR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIR
- VKTX
- Stock Information
- Founded
- MIR 2005
- VKTX 2012
- Country
- MIR United States
- VKTX United States
- Employees
- MIR N/A
- VKTX N/A
- Industry
- MIR Industrial Machinery/Components
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- MIR Technology
- VKTX Health Care
- Exchange
- MIR Nasdaq
- VKTX Nasdaq
- Market Cap
- MIR 3.3B
- VKTX 3.4B
- IPO Year
- MIR N/A
- VKTX 2015
- Fundamental
- Price
- MIR $13.80
- VKTX $23.94
- Analyst Decision
- MIR Strong Buy
- VKTX Strong Buy
- Analyst Count
- MIR 4
- VKTX 12
- Target Price
- MIR $18.75
- VKTX $89.75
- AVG Volume (30 Days)
- MIR 1.7M
- VKTX 4.5M
- Earning Date
- MIR 04-29-2025
- VKTX 04-23-2025
- Dividend Yield
- MIR N/A
- VKTX N/A
- EPS Growth
- MIR N/A
- VKTX N/A
- EPS
- MIR N/A
- VKTX N/A
- Revenue
- MIR $860,800,000.00
- VKTX N/A
- Revenue This Year
- MIR $5.67
- VKTX N/A
- Revenue Next Year
- MIR $7.44
- VKTX N/A
- P/E Ratio
- MIR N/A
- VKTX N/A
- Revenue Growth
- MIR 7.48
- VKTX N/A
- 52 Week Low
- MIR $9.11
- VKTX $18.92
- 52 Week High
- MIR $18.81
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- MIR 45.35
- VKTX 46.06
- Support Level
- MIR $13.56
- VKTX $18.92
- Resistance Level
- MIR $14.04
- VKTX $27.09
- Average True Range (ATR)
- MIR 0.80
- VKTX 2.31
- MACD
- MIR 0.03
- VKTX 0.26
- Stochastic Oscillator
- MIR 58.44
- VKTX 61.44
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.